Petri Polonen

20PUBLICATIONS
270CO-AUTHORS
Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)Innate immunityEpigenetics (incl. genome methylation and epigenomics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Apr 09, 2026
Genomic Insights into the Biology of T-lineage Acute Lymphoblastic Leukemia.

Petri Pölönen, David T Teachey, Charles G Mullighan

|Mar 06, 2026
Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia.

Danika Di Giacomo, Petri Pölönen, Valentina Bardelli

|Feb 11, 2026
CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia.

Jason Xu, Michael McCoy, Zachary Martinez

|Nov 21, 2025
Remodeling of the immune microenvironment is linked to adverse outcome in pediatric T cell acute lymphoblastic leukemia.

Caroline R M Wiggers, Eugene Y Cho, Merve Ozdemir

|Nov 12, 2025
A non-canonical lymphoblast in refractory childhood T-cell leukaemia.

Bram S J Lim, Holly J Whitfield, Mi K Trinh

Pageof 4